These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [LDL apheresis in the treatment of hyperlipoproteinemia]. Ishikawa K Nihon Rinsho; 1994 Dec; 52(12):3298-302. PubMed ID: 7853726 [TBL] [Abstract][Full Text] [Related]
3. [Reducing low density lipoprotein-cholesterol levels by apheresis]. Reiber I; Gógl A Orv Hetil; 1994 Mar; 135(11):563-8. PubMed ID: 8159408 [TBL] [Abstract][Full Text] [Related]
4. [Apheresis in severe hypercholesterolaemia]. Graesdal A; Hovland A; Bjørbaek E Tidsskr Nor Laegeforen; 2004 Apr; 124(8):1085-7. PubMed ID: 15114383 [TBL] [Abstract][Full Text] [Related]
5. [A case with homozygote familial hypercholesterolemia treated with LDL apheresis and coronary bypass in adolescence period]. Altinel E; Cetinkaya S; Kara C; Orün UA; Aydin H; Kutsal A Anadolu Kardiyol Derg; 2008 Jun; 8(3):231-2. PubMed ID: 18524734 [No Abstract] [Full Text] [Related]
6. LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia. Nenseter MS; Bogsrud MP; Græsdal A; Narverud I; Halvorsen B; Ose L; Aukrust P; Holven KB Thromb Res; 2012 Nov; 130(5):823-5. PubMed ID: 22728023 [No Abstract] [Full Text] [Related]
7. [Effects of LDL-apheresis--more than reduction of cholesterol?]. Schettler V; Wieland E Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636 [TBL] [Abstract][Full Text] [Related]
8. [The extracorporeal elimination of LDL cholesterol by apheresis. The indications and methods]. Olbricht CJ Dtsch Med Wochenschr; 1991 Apr; 116(16):625-30. PubMed ID: 2015780 [No Abstract] [Full Text] [Related]
9. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis. Mol MJ; Stalenhoef AF Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495 [TBL] [Abstract][Full Text] [Related]
10. Homozygous familial hypercholesterolaemia and treatment by LDL apheresis. King RI; Scott RS; Florkowski CM; Laurie AD; Reid N; George PM N Z Med J; 2010 Jul; 123(1319):79-82. PubMed ID: 20717180 [No Abstract] [Full Text] [Related]
16. [Biological efficacy of LDL apheresis in major hypercholesterolemia]. Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942 [TBL] [Abstract][Full Text] [Related]
18. [H.E.L.P. apheresis and oxidative stress]. Pulawski E; Mellwig KP; Horstkotte D Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600 [TBL] [Abstract][Full Text] [Related]
19. The use of combined LDL affinity apheresis utilizing dextran sulfate cellulose columns and hypolipidemic medications in patients with severe hypercholesterolemia to assess regression of atherosclerosis. Jones PH Beitr Infusionsther; 1988; 23():142-5. PubMed ID: 2484769 [No Abstract] [Full Text] [Related]
20. Treatment of severe hypercholesterolaemia by LDL-apheresis. Scarpato N; Gnasso A; Nappi G; Falco C; Postiglione A; Formisano S; Mancini M Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):53-60. PubMed ID: 1751680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]